The live streamed event will cover topics including DME, CME, AON and more.
In July, biopharmaceutical company Oculis Holding AG will hold its first R&D Day to highlight its clinical developments in retina care. In a press release, the company, headquartered in Switzerland, announced a live event in New York City which will also be broadcast online.1 The in-person and online showcase will be held Tuesday, 11 July, from 10AM to 12PM EDT.
Retina specialists will participate in presentations and a panel discussion. Topics that appear on the day's agenda include Diabetic Macular Edema (DME), Cystoid Macular Edema (CME) and Acute Optic Neuritis (AON).1 The news release also included details of the clinical programming Oculis will showcase during the event, which include:
Oculis also released a list of specialists and researchers who will participate in the day’s events. Presenters expected to appear include Sophie Bonnin, MD, neuro-retina specialist at the Foundation Rothschild Hospital, Paris; David S. Boyer, MD, University of Southern California Keck School of Medicine; Quan Dong Nguyen, MD, MSc, FARVO, FASRS, Byers Eye Institute, Stanford University School of Medicine; and Arshad M. Khanani, MD, MA, FASRS, University of Nevada, Reno School of Medicine.
Panelists in the Q&A session will include Pravin Dugel, MD, president of Iveric Bio; Sabri Markabi, MD, an independent R&D consultant; Ramin Tadayoni, MD, professor of ophthalmology at University of Paris; and Pablo Villoslada, MD, adjunct professor at Stanford University. Oculis CEO, Riad Sherif, MD, will lead the discussion; Bastian Dehmel, MD, head of development at Oculis, will also answer questions.
Registration is free through the Oculis website. The in-person event takes place at the Lotte New York Palace Hotel. The registration page includes a submission form so attendees may ask the panelists questions.